Concurrent Exercise Training
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Exercise, exercise.
- Who it may be relevant to
- Registry conditions: Typ 2 Diabetes. Basic parameters: 40 years — 60 years · Male.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Impact of Morning Versus Evening Concurrent High-Intensity Interval Training and Resistance Training on Glycemic Control in in Men With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
Overview
The goal of this clinical trial is to investigate the influence of morning versus evening concurrent training consisting of high-intensity interval training and resistance training on glycemic control in men with type 2 diabetes mellitus. The main questions it aims to answer are: • Which time is best for concurrent exercise training in diabetic patients, morning or evening? Researchers will compare morning versus evening concurrent training consisting of HIIT and RT on glycemic control in men with type 2 diabetes mellitus. Participants will: * Perform concurrent training consisting of high-intensity interval training and resistance training for 12 weeks * Visit the clinic before and after the 12-week experimental period for checkups and tests
Interventions
- Behavioral Exercise
Morning concurrent high-intensity interval training and resistance training - Behavioral exercise
evening concurrent high-intensity interval training and resistance training between 16:00 and 19:00
Primary outcome measures
- glycemic control [Time frame: baseline and at 12 weeks.]
Secondary outcome measures (2)
- lipid profile [Time frame: baseline and at 12 weeks]
- cardiorespiratory fitness [Time frame: at baseline and at 12 weeks]
Eligibility criteria
Inclusion criteria
- men aged 40-60 years with a diagnosis of T2D
- HbA1c levels between 7.0% and 9.0%
- treatment with oral hypoglycemic agents for at least 6 months
- a BMI <30 kg/m²
- a physically inactive
Exclusion criteria
- current insulin therapy
- a cardiovascular event within the previous 6 months
- cardiovascular, respiratory or musculoskeletal conditions that could limit participation in exercise training
- body weight instability
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07630025 · CT 2026 · 2025/03/33413